Replies to post #733 on Verastem (VSTM)

[instock58]

VSTM MOVING News on TOS and Benzinga 08:02 AM EDT, 09/22/2021 (MT Newswires) -- Verastem Oncology (VSTM) on Wednesday appointed Louis Denis chief medical officer.
Denis, who has more than 25 years of experience, previously served as chief medical officer of Asana BioSciences.

Finviz Rated
https://finviz.com/quote.ashx?t=VSTM

TradeView Buy Rated
https://www.tradingview.com/symbols/NASDAQ-VSTM/technicals/

$VSTM UP and maybe Up Up and Away !!

Verastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Louis J. Denis, M.D., as Chief Medical Officer. Dr. Denis brings more than 25 years of clinical development and oncology expertise to Verastem.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210922005333/en/

$VSTM